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Governor Baker Tours MetroWest Manufacturer MatTek Life Sciences, 
Pivoting to Support COVID-19 Research With Support from M-ERT 
  
ASHLAND — Governor Charlie Baker today toured MatTek Life Sciences, a Massachusetts-
based company of 35 years, that is currently participating in the Baker-Polito 
Administration’s Manufacturing Emergency Response Team (M-ERT). This initiative assists 
local manufacturers in transitioning operations to produce personal protective equipment 
(PPE) and other critical items needed to support the Commonwealth’s ongoing response 
to the COVID-19 public health emergency. 
  
Boasting a highly trained scientific staff, expertise in cell culture and building human 
tissues, and existing relationships with government agencies and the FDA, MatTek was 
uniquely positioned to shift their operations to support the Commonwealth’s response to 
COVID-19. The transition from the manufacture of cell culture media to the production of 
viral transport media was streamlined with support from the M-ERT’s experts, particularly 
MIT’s System Design and Management program. In MatTek’s normal operations, many of 
its 3D tissue types have been used in COVID-19 antiviral research - EpiAirway, EpiOral and 
EpiIntestinal - with the EpiAirway tissue being particularly relevant for this research, 
providing a human-based platform for scientists to get more relevant results much faster 
than if they used animals. 
  
In addition to providing essential products for COVID-19 research, six weeks ago MatTek 
also pivoted labs and staff into producing hand sanitizer, and has donated hundreds of 
liters to local first responders and medical facilities, and shipped thousands of liters across 
the country. 
  
MatTek has received grant support through the M-ERT’s funding program launched last 
month to substantially increase their output of viral transport media. The Massachusetts 
Life Sciences Center is among the M-ERT partners that have made capital funding 
available to pivoting manufacturers. 
  
About the Manufacturing Emergency Response Team (M-ERT): The M-ERT is a 
coordinated response by the Baker-Polito Administration and leading academic and 
industry stakeholders to support the Commonwealth’s manufacturers in their efforts to 
produce much-needed supplies for front-line workers and the health care system. The M-
ERT is led by the Massachusetts Technology Collaborative (MassTech) and members 
include representatives from: Massachusetts Life Sciences Center, Advanced Functional 
Fabrics of America (AFFOA), MIT, MIT Lincoln Labs, the University of Massachusetts 
Lowell, Worcester Polytechnic Institute (WPI), the Massachusetts Manufacturing 
Extension Partnership (MassMEP), Associated Industries of Massachusetts (AIM), and 
other industry partners. 
  
The M-ERT also launched $10.6 million in new funding to help manufacturers scale their 
operations to produce PPE and other critical items. Companies can apply for grants 
through an online form for equipment, materials, supplies, workforce training and other 
needs. A Review Committee will process applications based on criteria including 
production timeline and recommend grant awards. 
  
The M-ERT has graduated 27 companies that have produced almost 3 million PPE items to 
date. As of Thursday, 704 companies in total have reached out to participate in the M-ERT 
initiative, including 434 from Massachusetts. 
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